Sign in
Not yet taking people in South AfricaNo phase

Developing a Therapy for Mental Health and HIV Care in South Africa

Tests a new therapy for adults with HIV facing depression and hardship.

Key facts

Who runs it
Massachusetts General Hospital
Where
Cape Town, South AfricaSee the site
Trial code
Registry title
Intervention Development for Syndemics Among PWH in SA
Status
Not yet recruiting
People taking part
60 people, planned
Started
15 Sept 2026
Expected to end
30 Jun 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Cognitive Behavioral Therapy for Syndemics and Adherence (CBT-SA)
Record updated
9 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults receiving HIV care in Khayelitsha, South Africa, who have trouble taking their HIV pills, go short of food, and have signs of depression or trauma stress.

Age
18 years or older
Sex
All sexes can join
Disease stage
Mild, moderate, or severe food insecurity, plus clinically significant depressive symptoms (CES-D ≥ 16) or post-traumatic stress symptoms (SPAN ≥ 5)
Earlier treatment
Must currently be prescribed TDF-based ART, with recent difficulties taking it (self-reported in the past 30 days and confirmed by pharmacy refill data). In the past year, no CBT for depression or PTSD, and no food parcels or nutritional counseling.

Main reasons for not taking part

  • Cannot or will not give informed consent
  • Got CBT for depression or PTSD in the past year
  • Got food parcels or nutritional counseling in the past year
  • Has a serious mental health problem that is untreated or not treated enough and would get in the way of taking part

This trial only enrols participants living with HIV. The registry sentence this rests on: Patient receiving HIV care in Khayelitsha (confirmed by medical record)

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patient receiving HIV care in Khayelitsha (confirmed by medical record)
  • Currently prescribed TDF-based ART, with recent difficulties with ART adherence (self-reported in past 30 days / confirmed by pharmacy refill data)
  • Mild, moderate, or severe food insecurity (measured by HFIAS categories) AND ≥1 of the following:; Clinically significant depressive symptoms (CES-D ≥ 16); Clinically significant post-traumatic stress symptoms (SPAN ≥ 5)
  • 18 years of age or older

Who cannot take part

  • In the past year: received CBT for depression or PTSD, or received supplemental food parcels or nutritional counseling
  • Unable or unwilling to provide informed consent
  • Current untreated or undertreated serious mental health issue that would interfere with participation

Where in South Africa

  • University of Cape TownCape Town, South AfricaContact: Lindsay FesterNot yet recruiting

About the trial

What the trial wants to find out

In South Africa, the country with the highest HIV prevalence (19%), co-occurring problems such as depression, post-traumatic stress, and food insecurity interact to enhance one another (i.e., syndemic problems) and are associated with worse HIV outcomes such as worse antiretroviral therapy (ART) adherence and worse viral load. This study proposes to: 1) explore how syndemic problems work together to make health worse for people with HIV (PWH) and explore what people think about a potential treatment; 2) develop a treatment to address syndemic problems and improve ART adherence (CBT-SA); 3a) assess whether people are willing to receive the CBT-SA we it can actually be done; and 3b) identify factors that make it easier or more difficult to receive CBT-SA.

The 2 groups in the trial

  • Enhanced Treatment as Usual (ETAU)No study treatment, for comparison

    We anticipate the control condition will contain the following: the enhanced treatment as usual (ETAU; n=30) will consist of PWH receiving treatment at their HIV primary care clinic as usual, enhanced by supplemental food parcels and referrals for mental health care and food service organizations. Treatment as usual for mental health care is evaluation by a nurse and referral to a medical officer or to a traveling psychologist available 1 day per week. Because there is no standard of care for food insecurity, we propose that all participants will receive food parcels, but ETAU participants will not receive case management or psychosocial intervention.

  • Cognitive Behavioral Therapy for Syndemics and Adherence (CBT-SA)Treatment being tested

    We anticipate the intervention condition (CBT-SA) will contain the following: cognitive behavioral therapy for syndemics and adherence (CBT-SA; n=30) likely will be comprised of both psychosocial and structural intervention components, based on the results of Aim 1 and refinement in Aim 2. In addition to food parcels, we expect the CBT-SA condition will also receive nutritional counseling, linkage to care, and case management. Only the CBT-SA condition will receive the psychological intervention for depression and PTSD and adherence counseling. Specific intervention components will be informed by prior aims.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Developing and Piloting a Multilevel Intervention to Address Psychosocial and Structural Syndemics in People With HIV in South Africa
Plain-language title
Developing a Therapy for Mental Health and HIV Care in South AfricaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
9 September 2026